fr   en
Acquisitions
Select a company :
Choose date:
«      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10      »      
Date Acquiring pharma company Acquired biotech company Amount Terms / other
2006-11-20 Pfizer (USA) Rinat Neurosciences (USA) not disclosed See details
2006-11-09 Genentech (USA) Tanox (USA) $919 million, i.e. $20 per share See details
2006-10-30 Merck&Co (USA) Sirna (USA) $1.1 billion, i.e. $13 per share See details
2006-10-17 Eli Lilly (USA) Icos (USA) $2.1 billion See details
2006-10-08 Novartis (Switzerland) NeuTec Pharma (UK) A £305 million ($569 million) takeover bid (£10.5 per share) was announced in June, the final amount has not been disclosed. See details
2006-10-02 Gilead (USA) Myogen (USA) $2.5 billion, i.e. $52.5 per share See details
2006-10-02 Crucell (The Netherlands) Berna Products (Switzerland) $16.5 million See details
2006-09-29 Amgen (USA) Avidia (USA) An initial payment of $290 million, followed by milestone payments of up to $90 million See details
2006-09-22 Merck KGaA (Germany) Serono (Switzerland) Euro10.4 billion (CHF16.6 billion) See details
2006-08-29 Hesperion, the clinical research subsidiary of Cerep (France) Touchstone Research (USA) Initial payment of $3 million which could be completed with of additional milestone payments of up to $7 million. See details
2006-08-02 Gilead (USA) Corus Pharma (USA) $365 million See details
2006-07-02 Trinity Biotech the haemostasis division of bioMerieux Euro60 million See details
2006-06-13 Galapagos (Belgium) Discovery Partners International (DPI) Euro4.25 million in cash See details
2006-05-24 7TM Pharma (Denmark) CareX (France) The financial details have not been disclosed See details
2006-05-15 AstraZeneca CAT (Cambridge Antibody Technology) €1 billion See details
«      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10      »